PHV-wordings
Here you will find safety-relevant information that must be implemented in the corresponding product information due to a PHV (pharmacovigilance) issues.
Due to the relaunch of the EMA website in December 2023, you will find the current links to the entries prior to December 01, 2023 at https://www.ema.europa.eu
Alpha-1-Adrenozeptorenblocker
Additional template
|
28/02/2007
IFIS (Intraoperative Floppy Iris Syndrome).
Salbutamol
Additional template
|
01/02/2007
Myokardischämie.
Nicht steroidale Antirheumatika (NSAR)
Additional template
|
06/01/2007
Kardiovaskuläre Risiken - europaweite Neubewertung im Vergleich zu den "Coxiben".
